Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism HSP90 inhibitors(Heat shock 90kDa proteins inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC28H29F2N5O |
InChIKeyMKFMRDOLZREZKX-UHFFFAOYSA-N |
CAS Registry1240089-67-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Triple Negative Breast Cancer | Preclinical | SI | 23 Jul 2024 |